Background: We aimed to evaluate the diagnostic roles of AFAP1-AS1 and ASB16-AS1 in colorectal cancer and highlight their roles in predicting colorectal cancer patients' prognosis.
Methods: In this case-control study, 146 participants were involved. Group I included 47 patients with CRC.